Click on image to view larger version.

Figure 4 The PI3K inhibitor, wortmannin, inhibits the reperfusion salvage seen with 25 µmol/l atorvastatin. Wortmannin administered alone had no impact on infarction (*p < 0.05, atorvastatin group vs. control and wortmannin plus atorvastatin).